Skip to content
HowShorted

Co-Diagnostics, Inc. short interest in 2022

In 2022, Co-Diagnostics, Inc.'s disclosed short interest ran from 5.57% of shares outstanding on 14 Jan 2022 to 4.29% on 30 Dec 2022, a change of -1.28 percentage points. The year's high was 7.85% on 15 Nov 2022 and its low 4.21% on 29 Apr 2022, averaging 5.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.68 days on 15 Nov 2022. Full history: Co-Diagnostics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Co-Diagnostics, Inc. in 2022

2022 in figures

Start of year
5.57% (14 Jan 2022)
End of year
4.29% (30 Dec 2022)
Change
-1.28 pp
High
7.85% (15 Nov 2022)
Low
4.21% (29 Apr 2022)
Average
5.85%
Highest days to cover
15.68 (15 Nov 2022)
SEC filings marked
8

Every report in 2022

Co-Diagnostics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20225.57%1.77
31 Jan 20226.47%3.29
15 Feb 20226.78%8.45
28 Feb 20225.28%3.41
15 Mar 20225.30%3.27
31 Mar 20225.58%3.5410-K filed, results (8-K)
14 Apr 20225.99%8.87
29 Apr 20224.21%6.32
13 May 20226.63%8.0610-Q filed, results (8-K)
31 May 20225.46%3.34
15 Jun 20225.43%5.08
30 Jun 20225.58%4.25
15 Jul 20225.07%4.32
29 Jul 20226.10%2.08
15 Aug 20226.20%2.0910-Q filed, results (8-K)
31 Aug 20226.78%3.19
15 Sep 20226.90%5.23
30 Sep 20225.55%6.83
14 Oct 20226.01%10.41
31 Oct 20226.96%15.53
15 Nov 20227.85%15.6810-Q filed, results (8-K)
30 Nov 20225.85%12.58
15 Dec 20224.63%9.03
30 Dec 20224.29%6.84

See also: Co-Diagnostics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.